Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,200
Closed -$2.13M 1891
2025
Q4
$2.13M Sell
65,200
-58,548
-47% -$1.44M 0.03% 651
2025
Q3
$2.21M Buy
+123,748
New +$1.8M 0.03% 693
2025
Q2
Sell
-26,755
Closed -$495K 1796
2025
Q1
$495K Buy
+26,755
New +$483K 0.01% 1089
2024
Q4
Sell
-53,561
Closed -$751K 1638
2024
Q3
$751K Buy
+53,561
New +$592K 0.02% 930
2023
Q1
Sell
-18,500
Closed -$185K 1576
2022
Q4
$185K Sell
18,500
-9,099
-33% -$101K 0.01% 1310
2022
Q3
$329K Buy
+27,599
New +$276K 0.01% 1099
2022
Q2
Sell
-20,700
Closed -$164K 1608
2022
Q1
$164K Sell
20,700
-18,100
-47% -$156K 0.01% 1346
2021
Q4
$364K Buy
+38,800
New +$465K 0.02% 796

Other funds holding AXGN

Jump Financial's AXGN Position: Q1 2026 in Review

Jump Financial sold out of Axogen (AXGN) in Q1 2026, closing a stake of 65,200 shares — an estimated $2.13M sold.

Jump Financial first reported a position in AXGN in Q4 2021 and held it in 8 quarters. The position peaked at $2.21M in Q3 2025. 222 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Jump Financial reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 65,200 Axogen shares in Q1 2026, an estimated $2.13M.
  • Jump Financial first reported a position in Axogen in Q4 2021 and held it in 8 quarters.
  • Jump Financial's Axogen position peaked at $2.21M in Q3 2025.
  • 222 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.